Лазеротерапия иммунных нарушений при болезни Рейно
Д А Рахмонов, Д. Д. Султанов, N.T. Gulmuradova et al. · 2020
Purpose . To study the effectiveness of intravenous laser blood irradiation (ILBI) for the correction of immune disorders in Raynaud’s disease. Material and methods . The researchers evaluated outcomes of examination and management of 57 patients with Raynaud’s disease. 40 (70.2%) women and 17 (29.8%) men. The angiospastic stage was registered in 7 patients, the angioparalytic stage - in 31 and the stage of trophic disorders - in 19. All patients had conservative therapy. Immunostimulating drugs were not prescribed. Ultrasound Dopplerography and duplex scanning were used to study blood circulation in hands. To assess the immune status, the following parameters of cellular chain - (CD 3 (T-rosettes), CD 4 (T-helpers), CD 8 (T-suppressors), CD 20 (B-lymphocytes), CD 95 (apoptosis), CD 16 (NK-cells), CD 71 ( proliferation receptor) and CD 32 (phagocytosis) - as well as the humoral chain (serum immunoglobulins LgA, IgM, IgG) were tested. For the immunocorrection, ILBI technique was applied with laser device Mustang-2000 (Russia): wavelength - 0.63 μm, radiation frequency 80 Hz, power - 2.0 mW, exposure - 20 min, course - 10 daily sessions. Results . All patients with Raynaud’s disease prior to ILBI had the established significant decrease in blood flow in the arteries of their hands, dysfunction of cellular and humoral chains of the immune system, in particular: suppression of all types of T-lymphocytes; decrease of serum immunoglobulins of class A and increase in immunoglobulins of class M in blood. After 10 ILBI sessions, one could observe normalized parameters of both cellular and humoral chains of the immunity. Conclusion . ILBI with low-level laser therapy as a part of complex treatment normalizes immune system, improves microcirculation in hands as well as leads to the regression of main symptoms of Raynaud’s disease.
Cited by 0 works.